Two windows, one headline
A Danish cohort published this week puts three percentages on the table. Girls exposed to paracetamol before birth had, on average, ovaries 40 per cent smaller by volume, uteruses 13 per cent smaller by volume and 23 per cent fewer ovarian follicles than girls who were not exposed. A follicle is the sac that nurtures an immature egg, so the third figure is the one that sounds like a verdict on future fertility.[1]
The percentages do not all come from the same children. In the study report the volume differences belong to girls whose mothers took paracetamol before 17 weeks of pregnancy, and the follicle difference to girls exposed at or after 17 weeks. The early group holds 92 girls, the mid-to-late group 67 and the unexposed comparison group 143, while the hormone finding rests on a subgroup of 22 girls exposed only in early fetal life.[1]
The absolute difference, and the denominator
In absolute terms these are small numbers. Ovarian volume differed by 0.11 cubic centimetres, with a confidence interval running from 0.03 to 0.19. Uterine volume differed by 0.16 cubic centimetres and the follicle count by 1.05 follicles. A proportion of 40 per cent on a structure that stays below one cubic centimetre at three months of age describes a very small structure, and it does not become the kind of quantity a clinician weighs at the bedside.[1]
The comparison is observational, and the reason a woman reaches for paracetamol travels with the exposure. Fever, pain and the conditions behind them are themselves candidates for the difference. The authors report that the results held after accounting for fever and other maternal factors, and they also write plainly that residual confounding by indication cannot be completely excluded. The strongest reading in the other direction is the dose pattern: maternal urinary paracetamol concentrations were inversely associated with ovarian and uterine volume, and that is harder to produce from the reason for taking the drug alone.[1]
What the guidance says
None of this changed the advice. Paracetamol remains the recommended option in pregnancy for high fever or strong pain, and the risk of leaving those untreated is concrete. Where the study does bear down is the ordinary case: most of the women in the cohort took paracetamol for headaches or musculoskeletal pain rather than fever, and for that use it is now reasonable to ask whether rest, heat treatment or physiotherapy would do instead.[1]
The unexposed comparison group was not assembled by randomisation; it was assembled by classifying 143 girls whose mothers reported no paracetamol. The effect estimate is only as sound as the group it is set against, and nothing here says what happens to these girls’ fertility in adulthood.[1]